Tag: mrna_vaccine
-
Harvard's Bill Hanage on an Early Flu Season, Vulnerability and the First mRNA Flu Vaccine
Harvard Gazette highlights a conversation with Chan School epidemiologist Bill Hanage on the flu season's early start, who is most at risk, and the first-ever mRNA flu vaccine.
HealthScience & TechnologyEducationMedical ScienceArtificial IntelligencePolitics and Government Bill HanageHarvard T.H. Chan School of Public Healthflu seasonmRNA vaccineHarvard Gazettepublic healthPh.D. training
-
Media Monitor: FDA Approves Moderna mRNA Flu Vaccine; Health Costs to Rise
TIME Health reports on the FDA's approval of Moderna's mRNA flu vaccine for adults 50 and older, projected health insurance premium increases, and challenges to Medicaid for the homeless.
HealthScience & TechnologyBusinessPolitics and GovernmentMedical ScienceArtificial IntelligenceEconomySocial IssuesFederal GovernmentAstronomy and Space ModernamRNA vaccineInfluenzaFDAHealth InsuranceMedicaidLonelinessTIME Health